Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23105526
Abstract: Depression is characterized by continuous low mood and loss of interest or pleasure in enjoyable activities. First-line medications for mood disorders mostly target the monoaminergic system; however, many patients do not find relief with these… read more here.
Keywords: endocannabinoid system; components depression; depression; ecs components ... See more keywords